While we have demonstrated that KIF1B represents a promising novel therapeutic target for asthma treatment through its effective prevention of oxidative stress and inflammation‐mediated pyroptosis/lung injury, the study has several limitations that warrant consideration. Here, KIF1B is linked to asthma.